Clark Estates Inc. NY Has $3.63 Million Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Clark Estates Inc. NY cut its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 10.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 93,652 shares of the company's stock after selling 11,348 shares during the quarter. Bath & Body Works accounts for 0.7% of Clark Estates Inc. NY's portfolio, making the stock its 24th largest position. Clark Estates Inc. NY's holdings in Bath & Body Works were worth $3,631,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in BBWI. FMR LLC boosted its stake in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock valued at $80,315,000 after purchasing an additional 2,501,828 shares during the period. KBC Group NV boosted its stake in Bath & Body Works by 9,023.5% during the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after acquiring an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH bought a new position in Bath & Body Works during the 3rd quarter valued at $50,483,000. Senvest Management LLC bought a new position in Bath & Body Works during the 3rd quarter valued at $30,537,000. Finally, Principal Financial Group Inc. boosted its stake in Bath & Body Works by 328.7% during the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock valued at $34,153,000 after acquiring an additional 820,379 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Citigroup upgraded shares of Bath & Body Works from a "neutral" rating to a "buy" rating and increased their price objective for the company from $40.00 to $48.00 in a research note on Friday, February 28th. Cowen reiterated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Piper Sandler increased their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a report on Monday, January 6th. Finally, Barclays dropped their target price on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a report on Monday, March 3rd. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average target price of $45.06.

Bath & Body Works Price Performance

Shares of BBWI stock traded down $1.54 during trading hours on Friday, reaching $32.66. The stock had a trading volume of 4,652,756 shares, compared to its average volume of 3,886,149. The firm has a 50-day simple moving average of $37.37 and a 200-day simple moving average of $34.18. The firm has a market capitalization of $7.07 billion, a PE ratio of 7.97, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has approved a stock buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were paid a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.45%. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.